Navigation Links
Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis

NEW YORK, Nov. 25 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Intranasal Drug Delivery - US Market Trends & Analysis

The US intranasal drug delivery market is witnessing an expansion of therapeutic applications from the delivery of conventional local therapeutic drugs to the delivery of systemic therapeutic drugs. The future of the technology hinges onto the effective exploitation of the fact that the nose offers an en-route that bypasses the blood-brain barrier through the olfactory region. The market also stands enthused by the continuous research and development activities, which are gradually opening up opportunities in new therapeutic areas, such as, osteoporosis, pain management, vitamin B12 deficiency, smoking cessation, migraines, nocturnal enuresis, rheumatoid arthritis, sexual dysfunction, cancer therapy, insulin-dependent diabetes, and epilepsy.

These and other market data and trends are presented in "Intranasal Drug Delivery: US Market Trends & Analysis" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.




Study Reliability and Reporting Limitations 1

Disclaimers 2

Quantitative Techniques & Reporting Level 3


Drug Delivery: A Quick Primer 3

The Nose: An Attractive Avenue to Cross the Blood Brain Barrier 4

Self-Administration of Drugs Brings Intranasal Drug Delivery Into the Spotlight 5

Research & Technology Opens Up New Therapeutic Areas for Nasal Drug Delivery 5

Recent Product Developments in the US Intranasal Drug Delivery Market (2007) 6

R&D: Critical to the Commercialization of Intranasal Drug Delivery 6

Tight Junction Biology: A Key Speed Breaker in Commercialization 7

RNA Interference (RNAi): A Tool To Manipulate Tight Junctions 7

Why Is Nasal Drug Delivery the Theme of All Drug Delivery Research Projects? 8

Nasal Drug Delivery Devices & Equipments Preservative Free Systems (P.F.S.) 8

Traditional Vs Advanced Intranasal Drug Delivery Devices 10

Pitfalls Of Traditional Delivery Devices 10

The Promise of New Advanced Delivery Devices 10

Bi-Directional Nasal Drug Delivery: A Technology With a Huge Potential 10

Benefits of Bi-Directional Delivery Authenticated Through Research Studies 11

Market for Nasal Spray Devices in the US 12

GSK Wields the Leadership Scepter in the US Intranasal Drugs Market 12

The Batting Order 13


Innovation in Drug Delivery: A Talisman for Success 13

Controlled Release Technology is the Buzz Word 13

Target-Specific Delivery Devices: Of Critical Value 14

Safety & Cost: Primary Growth Drivers 14

Preservatives Losing Sheen in Nasal Spray Formulations 14

Multi-Dose Containers Evolve to Offer Resistance Against Microbial Contamination 15

Bioavailability: An Important Facet of Intranasal Drug Delivery 15

Chemical Modification 15

Transient Modification & Limited Enzymatic Activity 16

Bioavailability of Large Molecules 16

Bio-Adhesive Polymers: Useful in Increasing Drug Absorption 16

Mixed Opinions on Efficiency of Calcitonin Nasal Spray 16

Nasal Preparations Gaining Foothold in Cough and Allergic Categories 17

Patent Expiries Impact Market Opportunities 17



New-Generation Technologies and Devices 21

ViaNase from Kurve Technology 21

A New Product from OptiNose 21

Nastech's "Tight Junction Biology" Research Program 22

ChiSys(TM) Nasal Delivery Technology from Archimedes 22


Zelos Therapeutics Collaborates with Aegis Therapeutics 23

ImmuneRegen BioSciences Partners with LRRI 23

Avamys(TM) Nasal Spray Receives Approval in Europe 23

PMI-150 Receives Canadian Patent 23

Nastech Enrolls 551 Patients for Phase 2 Trials of PYY3-36

Nasal Spray 24

USFDA Approves FluMist® for Young Children 24

USFDA Approves Veramyst Nasal Spray for Individuals Aged Two Years and Above 24

Kurve Technology Inks Agreement with Schering-Plough 24

MedImmune Clarifies FDA Observations 25

FluMist(R) Receives FDA Approval for Refrigerated Formulation 25

Nastech Regains Rights for PTH1-34 Nasal Spray 25

NASONEX(R) Receives Ease-of-Use Commendation from Arthritis Foundation 25

Aegis Therapeutics Establishes Cedar Therapeutics Inc. 25

EMEA Provides Encouraging Feedback for Avamys(TM) Nasal Spray 25

Kurve Technologies Introduces Blog on Nasal Drug Delivery 26

Archimedes Pharma Commences Phase III Trials for NasalFent® 26

Archimedes Presents New Clinical Data on NasalFent® 26

LigoCyte Commences Clinical Trials for Intranasal Norovirus Vaccine 27

Javelin Pharmaceuticals Reveals Phase 2 Study Results for PMI-100/150 27

Javelin Pharmaceuticals Commences Phase III Studies for PMI-150 27

Nastech Commences Phase 2 Trials for Insulin Nasal Spray 27

ACAAI Reveals Results for Trials of Nasacort® AQ Nasal Spray in Children 28


Aegis Therapeutics LLC (USA) 28

Alza Corporation (USA) 28

AptarGroup, Inc. (USA) 29

Archimedes Pharma Limited. (UK) 29

AstraZeneca Plc (UK) 29

MedImmune, Inc. (USA) 29

Bayer Consumer Care (USA) 30

Bespak Plc (UK) 30

GlaxoSmithKline Plc (UK) 30

Intranasal Therapeutics, Inc. (USA) 30

Javelin Pharmaceuticals, Inc (USA) 31

Kurve Technology, Inc. (USA) 31

MDRNA, Inc. (USA) 31

Novartis AG (Switzerland) 31

OptiNose AS (Norway) 32

Pfizer, Inc. (USA) 32

Rexam Plc (UK) 32

Schering-Plough Corporation (USA) 32

Sanofi-Aventis S.A. (France) 32

Unigene Laboratories, Inc. (USA) 33



Table 1: The US Nasal Drug Delivery Market: Sales Of Top Six Nasal Formulations for The Year 2005 (In US$ Million)

Table 2: Percentage Market Shares of Leading Intranasal Drug Delivery Players in the US - 2006

Table 3: Percentage Shares of Intranasal Drugs Manufacturer Value in the US - 2012

Table 4: Top 10 Nasal Sprays, Drops and Inhalers Brands Ranked by Dollar Sales Through Drug Stores in the US - 2008 (In US $ Million)

Table 5: Top 10 Nasal Sprays, Drops and Inhalers Brands Ranked by Unit Sales through Drug Stores in the US - 2008 (In Thousand Units)

Table 6: Top Five Nasal Sprays Ranked by Dollar Retail Sales in the US - 2008 (In US $ Million)

Table 7: Projected Revenues for Intranasal Sexual Dysfunction Drugs in the US -2010, 2011 & 2012 (in US$ Million)

Table 8: Intranasal Drug Delivery Market by Therapeutic Area in the US: 2007-2015 (Sales in US$ Million)

Table 9: Percentage Breakdown of Intranasal Drug Delivery Market by Therapeutic Area in the US for the Years 2008 & 2012


To order this report:

Drug Delivery Technology Industry: Intranasal Drug Delivery - US Market Trends & Analysis

More Market Research Report

Nicolas Bombourg
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker

Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015
2. Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015
3. Reportlinker Adds U.S. Market for PACS and EMR
4. Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective
5. Reportlinker Adds Holter Monitoring Systems - A Global Market Review
6. Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review
7. Reportlinker Adds Anesthesia Disposables - A World Market Review
8. Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis
9. Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth
10. Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective
11. Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015
Post Your Comments:
(Date:10/12/2015)... , Oct. 12, 2015  Edwards Lifesciences Corporation (NYSE: ... valves and hemodynamic monitoring, plans to announce its operating results ... closes on Monday, October 26, 2015, and will host a ... those results. . A live stream and ... downloading Edwards, IR App for iPhone and iPad ...
(Date:10/12/2015)... , October 12, 2015 --> ... insights on the global vital signs monitoring devices market in ... Industry Analysis and Opportunity Assessment 2015-2025." The global vital signs ... CAGR of 9.5% and 9.2% in terms of value and ... which FMI offers major insights in detail in this report. ...
(Date:10/12/2015)... Oct. 12, 2015 Beginning October 1, 2015 ... Partner, the fastest growing practice management system for therapists, ... easily converts all patient diagnostic codes from the former ... --> --> Therapy Partner has ... mental health practitioners to easily understand the conversion to ...
Breaking Medicine Technology:
(Date:10/12/2015)... ... ... American Family Care (AFC), the nation’s leading provider of urgent care and ... Located at 606A Boll Weevil Circle in Enterprise, it is the company’s ninth location ... quality health care accessible and economical with the opening of our medical center in ...
(Date:10/12/2015)... ... October 12, 2015 , ... Etymotic Research, manufacturer ... version of Companion Mics, the CM•4 Multi-Talker Noise Reduction System, as well as ... Aid Acousticians’ (EUHA) 60th Annual Congress in Nuremberg, Germany. , The conference ...
(Date:10/12/2015)... , ... October 12, 2015 , ... ... IQ Formulations today announced its charitable donation to the National Breast Cancer Foundation. ... in those affected by breast cancer through early detection, education, and support services. ...
(Date:10/12/2015)... , ... October 12, 2015 , ... Holcomb – Kreithen ... practices in Florida, announced today that it will host “Plastic Surgery University,” an educational ... University Town Center (“UTC Mall”) in Sarasota, FL on Saturday, October 24, 2015. ...
(Date:10/12/2015)... ... October 12, 2015 , ... International law firm Greenberg Traurig, ... the U.S. Biomedical Advanced Research and Development Authority (BARDA) reported to be worth ... Autologous Cell Harvesting Device under a U.S. mass casualty preparedness program. ...
Breaking Medicine News(10 mins):